XML 35 R15.htm IDEA: XBRL DOCUMENT
v3.21.2

Earnings Per Share | 6 Months Ended
--- | ---
Jun. 30, 2021
Earnings Per Share [Abstract] |
Earnings Per Share | Earnings Per Share Earnings per share is computed using the two-class method. Stock appreciation rights and options to purchase 8 million and 9 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and six months ended June 30, 2021, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive. For the same reason, stock appreciation rights and options to purchase 17 million and 15 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and six months ended June 30, 2020, respectively. The following is a reconciliation of basic and diluted earnings per share for the respective periods:
| Three Months Ended June 30, |  | Six Months Ended June 30,
In millions, except per share amounts | 2021 |  | 2020 |  | 2021 |  | 2020
Numerator for earnings per share calculation: |  |  |  |  |  |  |
Net income attributable to CVS Health | $ | 2,783 |  |  | $ | 2,975 |  |  | $ | 5,006 |  |  | $ | 4,982 |
Denominator for earnings per share calculation: |  |  |  |  |  |  |
Weighted average shares, basic | 1,319 |  |  | 1,309 |  |  | 1,316 |  |  | 1,307 |
Effect of dilutive securities | 8 |  |  | 5 |  |  | 9 |  |  | 6 |
Weighted average shares, diluted | 1,327 |  |  | 1,314 |  |  | 1,325 |  |  | 1,313 |
Earnings per share: |  |  |  |  |  |  |
Basic | $ | 2.11 |  |  | $ | 2.27 |  |  | $ | 3.80 |  |  | $ | 3.81 |
Diluted | $ | 2.10 |  |  | $ | 2.26 |  |  | $ | 3.78 |  |  | $ | 3.79 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration